01—Abstract
Summary
Summary of the 8-K filed February 6, 2025. Cited figures are marked; the original filing is the authoritative source.
Affirm Holdings (AFRM) reported fiscal Q2 2025 results (quarter ended December 31, 2024) that exceeded its own prior outlook on every financial metric, with a clear pivot toward sustained profitability.
Revenue rose 47% to $866 milliona, GMV grew 35% to $10.1 billion, and Revenue Less Transaction Costs (RLTC) jumped 73% to $419 million, or 4.1% of GMV. GAAP operating loss narrowed sharply to roughly breakeven ($4 million loss versus $172 million a year earlier), and the company posted net income of $80 million, versus a $167 million loss in the prior-year period. Management stated that it expects GAAP operating income profitability in FQ4 2025.
Quality of the improvement deserves some scrutiny. Part of the RLTC gain came from a $736 millionb ABS securitization and a $500 million loan sale, which together contributed roughly $60 million to RLTC, and RLTC as a percentage of GMV slightly exceeded the company's 3-4% long-term target range for that reason. Gain on sale of loans rose 138%, and funding costs fell about 50 basis points to 7.2%, a tailwind management attributes partly to a higher mix of loan sales.
Operating income also absorbed $101 millionc of enterprise warrant and share-based expense tied to enterprise partners, so GAAP results remain sensitive to these non-cash items. Delinquencies were roughly flat year over year after pricing initiatives extended credit to more consumers, and the company's allowance for credit losses stood at 5.4% of loans held for investment. Forward guidance calls for FQ3 2025 GMV of $8.0-8.3 billion and FQ4 2025 GMV of $9.0-9.3 billion, with full-year FY25 RLTC of $1.42-1.45 billion and adjusted operating margin of 22.5-23.5%.
Growth drivers include Affirm Card (GMV more than doubled to $845 milliond, with about 1.7 million active cardholders), the UK launch, a GoodRx partnership, and a Sixth Street forward-flow agreement of up to $4 billion in committed capacity. Total funding capacity rose to $22.6 billion from $16.8 billion in the prior quarter. The company also refinanced most of its 2026 convertible notes into 0.75% notes due 2029, and it has $1.2 billion in convertible debt outstanding against about $1.9 billion in liquidity.
02—Key points
Key Highlights
- Revenue grew 47% year over year to $866 million, and revenue as a percentage of GMV rose 65 basis points to 8.5%.
- RLTC grew 73% to $419 million (4.1% of GMV, up 91 bps). About $60 million of the benefit came from a $736 million securitization and a $500 million loan sale, and RLTC slightly exceeded the 3-4% target range as a result.
- GAAP operating loss narrowed to $4 million from $172 million a year earlier. Net income was $80 million, compared with a $167 million loss in the prior-year quarter.
- Adjusted operating income rose to $238 million (27% margin) from $93 million, but GAAP operating results still include $101 million of enterprise warrant and share-based expense.
- Funding capacity grew to $22.6 billion from $16.8 billion, and the Sixth Street partnership commits up to $4 billion in capacity to buy loans, supporting roughly $8 billion in annual loan sales at scale.
- Management expects GAAP operating income profitability in FQ4 2025, with FY25 GMV guidance of $34.7-35.3 billion and RLTC of $1.42-1.45 billion.
- Affirm Card GMV more than doubled to $845 million, active cardholders approached 1.7 million, and the company refinanced most of its 2026 convertible notes into 0.75% notes due 2029.
03—Questions
Frequently Asked Questions
Is Affirm now consistently profitable on a GAAP basis?
Not yet on an operating basis. Operating loss was $4 million in the quarter, roughly breakeven. Net income of $80 million was boosted by a $67 million gain on debt extinguishment and other income. Management expects GAAP operating income profitability in FQ4 2025 and intends to maintain it going forward.
How sustainable are the RLTC and unit economics gains?
Part of the gain was one-time in nature. Roughly $60 million of RLTC came from a large securitization and loan sale, and gain on sale of loans rose 138%. Funding costs also fell about 50 bps, partly due to a higher mix of loan sales. Management argues the underlying transaction cost improvements are durable, but the quarter's RLTC rate was above the company's 3-4% target range, so investors should separate recurring from transactional benefits.
What are the main credit risks?
Delinquencies declined sequentially on normal holiday seasonality but were slightly higher year over year because of pricing initiatives that extended credit to more consumers. The company estimates recent monthly installment cohorts will reach about 3.5% cumulative net charge-offs, in line with historical non-pandemic cohorts. Provision for credit losses was $153 million, and the allowance stood at 5.4% of loans held for investment.
What is the outlook for the rest of fiscal 2025?
Guidance calls for FQ3 2025 GMV of $8.0-8.3 billion and FQ4 2025 GMV of $9.0-9.3 billion, with FY25 revenue of $3.13-3.19 billion and RLTC of $1.42-1.45 billion. The adjusted operating margin is expected to be 22.5-23.5% for the full year. Management also expects benchmark rates to decline during FY25, which would be a tailwind to RLTC.
How is Affirm funding its growth, and what dilution or leverage risks exist?
Funding capacity reached $22.6 billion, supported by a $3.3 billion ABS issuance year to date in calendar 2024, $5.1 billion of added forward-flow capacity, and warehouse facilities. Liquidity was about $1.9 billion against $1.2 billion of convertible debt. The company repurchased $960 million of its 2026 convertible notes, leaving about $249 million outstanding, and authorized up to $500 million in additional repurchases through 2025, none of which had been used. Enterprise warrant expense also remains a source of non-cash dilution and GAAP volatility.
04—Continue